Arboretum LifeSciences is a molecular information company headquartered in Cambridge, Massachusetts, working to make precision medicine a reality for common diseases such as cardiovascular, metabolic and autoimmune conditions. Founded by leaders of the Broad Institute's Data Sciences Platform, it combines AI with clinical genetic testing — giving health systems a turnkey testing and research-network offering and giving biopharma genomically stratified trial design, patient matching and datasets for target discovery. It launched with healthcare partnerships including Advocate Health, Geisinger, Providence Healthcare and Cardiovascular Associates of America.
1
Round
1
Industry
4
Tags
Oct 6, 2026
Latest raise
Funding activity · 1 round
Oct 6, 2026
$30M
Series A
Led by F-Prime Capital
Article coming soon.
Pricing
Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.
For individuals and small teams getting started with AI buyer intelligence.
$149
/month
Features
For outbound teams and agencies that need more coverage and faster signal cadence.
$249
/month
Features
Act on this raise
Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.
